Mainly Flaking.
Usually limited to the scalp and generally considered a milder form within the seborrheic dermatitis spectrum.
Flaking is easy to see. The reason behind it is not always obvious.
Seborrheic dermatitis is a common, recurrent inflammatory skin condition that often affects the scalp and other oil-rich areas of the face and body. Dandruff is generally considered a milder, scalp-limited form of seborrheic dermatitis.
Persistent scale, itching, redness or recurrent facial involvement may require more than simply changing shampoo.

Flaking does not automatically mean that the scalp is dry.
Distribution, inflammation, type of scale and response to previous treatment help distinguish these problems.
Usually limited to the scalp and generally considered a milder form within the seborrheic dermatitis spectrum.
May involve the scalp, eyebrows, sides of the nose, ears, beard area, eyelids or upper chest.
Dryness can also cause fine flaking, but it does not follow the same inflammatory and sebaceous distribution.

Seborrheic dermatitis favors areas with higher sebaceous activity.
Some patients notice only dandruff. Others develop recurrent inflammation in several characteristic locations.
Seborrheic dermatitis appears to reflect an interaction between skin yeast, sebaceous lipids, barrier function and an individual inflammatory response.
Malassezia normally lives on human skin. Seborrheic dermatitis is not simply a contagious fungal infection.
The condition favors oil-rich regions of the scalp, face and upper body.
Individual inflammatory responses influence redness, itching and the degree of scale.
Scratching, irritating products and barrier disruption may contribute to symptoms.


Seborrheic dermatitis is not usually a primary cause of permanent follicular hair loss.
Significant inflammation, scratching or an accompanying scalp condition may contribute to increased shedding. Seborrheic dermatitis can also coexist with an unrelated hair-loss disorder.
If shedding continues after the scalp improves, or if density is progressively changing, hair loss should be evaluated separately.
Most cases can be diagnosed from history and clinical examination.
A closer evaluation is particularly useful when the presentation is unusual, significant hair loss is present or treatment repeatedly fails.
Thicker or more sharply defined plaques may suggest psoriasis, although overlap can occur.
Hair dyes, fragrance, preservatives and styling products can cause allergic or irritant scalp dermatitis.
Fungal infection can produce scaling, inflammation and hair loss and requires different treatment.
Atopic dermatitis may involve the scalp or face as part of a broader eczema pattern.
Pain, pustules, scarring or progressive hair loss may point to another diagnosis.
Treatment should match where the dermatitis occurs, how inflammatory it is and how often it returns.
The objective is not simply to remove visible flakes for a few days, but to create a practical strategy for recurrent disease.
Depending on the presentation, anti-dandruff or antifungal shampoos may include ingredients such as ketoconazole, ciclopirox, selenium sulfide or zinc pyrithione.
Topical antifungal medications may help manage yeast-associated inflammation in facial and body areas.
Short courses of appropriately selected topical corticosteroids or steroid-sparing anti-inflammatory agents may be used according to location and severity.
Roflumilast foam 0.3% is an FDA-approved nonsteroidal topical option for seborrheic dermatitis in patients 9 years of age and older.
Selected scale-control ingredients may be useful when scale is prominent, but overly aggressive cleansing can worsen barrier irritation.
Extensive or treatment-resistant dermatitis may occasionally require additional therapy, but persistent disease should first prompt reconsideration of the diagnosis and current regimen.
Seborrheic dermatitis may involve different areas and may require a different treatment strategy from patient to patient.
Individual treatment and results vary.
Seborrheic dermatitis is common. Persistent scale, however, is not always simple dandruff.
Dr. Viktoryia Kazlouskaya is board-certified in dermatology and dermatopathology. This perspective is particularly useful when scalp or facial dermatitis is atypical, resistant to treatment or occurring together with hair loss.
The goal is to identify what is driving the symptoms, simplify treatment when possible and create a practical long-term plan.
Seborrheic dermatitis becomes easier to manage once the diagnosis, treatment strategy and maintenance plan are clear.
Dandruff is generally considered a milder form within the seborrheic dermatitis spectrum. It is limited to the scalp and usually has less visible inflammation.
Not simply. Seborrheic dermatitis often affects oil-rich areas and appears to involve interactions among Malassezia yeast, skin lipids, barrier function and inflammation.
It is typically a chronic, relapsing condition. Maintenance treatment can therefore be useful after an active flare is controlled.
Yes. Common facial areas include the eyebrows, sides of the nose, ears, beard area and eyelids. It can also affect the chest and other sebaceous regions.
It is not usually a primary cause of permanent follicular hair loss. Significant inflammation or scratching may contribute to shedding, while another hair-loss disorder may also occur at the same time.
Depending on the presentation, treatment may include shampoos containing ketoconazole, ciclopirox, selenium sulfide or zinc pyrithione. Frequency should be individualized.
Many medicated shampoos need adequate time on the scalp before rinsing. Instructions vary, so the regimen should follow the specific product or physician recommendation.
Roflumilast foam 0.3%, marketed as Zoryve, is an FDA-approved nonsteroidal topical option for seborrheic dermatitis in patients 9 years of age and older.
Evaluation is particularly useful when dandruff does not improve with an appropriate regimen, when inflammation is significant, or when pain, pustules, hair loss or unusual distribution are present.
No. Seborrheic dermatitis is usually diagnosed clinically. Biopsy may be useful when the presentation is atypical, treatment-resistant or another diagnosis is suspected.
Persistent dandruff, scalp itching or recurrent facial scale may benefit from a dermatologist-led diagnosis and a plan designed for both active flares and maintenance.